SLIDE 8 12/9/16 8 Medication Assisted Treatment and
MAT: Pharmacotherapy plus counseling and behavioral therapies
Question
- Which of the following are currently approved medications for Opioid
Use Disorder?
- A) Methadone, buprenorphine, naloxone
- B) Methadone, buprenorphine, acamprosate, naltrexone
- C) Methadone, buprenorphine, naltrexone
- D) Methadone, buprenorphine, clonidine
MAT for Opiate Use Disorder – Options
Buprenorphine/naloxone (Suboxone, Bunavail, Zubsolv)
- Partial opioid agonist
- Ceiling effect – resp depression,
sedation
- Films or Pills (buprenorphine –
Subutex)
- Office based tx
- Stable pts – no poly drug use,
support system in place , psychologically stable
- MUST be in withdrawal to start
- Probuphine – next slide
Methadone maintenance (MMTP)
- Full opioid agonist
- Higher risk for OD,
sedation
- Liquid form, daily dosing
- Federally qualified OTP
(opiate tx program)
- Highly regulated, structure
- Counseling mandated
- Pts in need of monitoring,
lack of support system, psychologically unstable, failed Suboxone
to start
Naltrexone
- Opioid blocker
- NO risk for OD
- Pill or injection (Vivitrol)
- Office based
- Pts who are having cravings, not
experiencing any withdrawal, not currently using
- Stable pts - no poly drug use,
support system in place , psychologically stable (not for pts who have failed MMTP and/or Suboxone)
Probuphine
- FDA approved May 2016
- Long acting buprenorphine subdermal implant, 6 months
- Physician-certified, minor procedure – upper arm
- Pre-requisite
- Stable on buprenorphine/suboxone 8/2mg daily for at least 3 months
- Still recommend monthly visits for ongoing counseling and
psychosocial support